Medical University Of Warsaw — Clinical Trial Site

15 Registered trials

8 Currently recruiting

Organisation

Medical University Of Warsaw

Location

Warsaw, Poland

Identifier

ORG-100005121

Address

Ul. Zwirki I Wigury 61, 02-091, Poland

Departments

1st Department and Clinic of Cardiology
2103: Klinika Hematologii, Transplantologii i Chorob Wewnetrznych
Cardiology
Department of Paediatrics and Nephrology, Medical University of Warsaw
Diabetology
First Department of Cardiology
Katedra i Klinika Pediatrii i Nefrologii
Klinika Hematologii, Transplantologii i Chorób Wewnętrznych
Klinika Kardiologii
Klinika Neurologii
Klinika Onkologii
Oddział Kliniczny Chorób Wewnętrznych i Endokrynologii
Oncology
Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego

Clinical trials at this site (15)

Search interface

Phase 3, Multicenter, Randomized, Open-label Clinical Study of GSK5764227, a B7-H3 Antibody Drug Conjugate (ADC), compared with Topotecan in… Recruiting

2025-521627-78-00 Neoplasms, Lung 5 2026-01-28
An investigational trial to evaluate the effects of the drug XC001 delivered via a catheter in subjects with chronic angina caused by corona… Recruiting

2024-514874-36-01 Refractory angina due to obstructive coronary artery di 4 2026-04-17
Evaluation of the efficacy and safety of prolonged-release budesonide in children with primary IgA nephropathy. Recruiting

2024-518759-45-00 Children primary nephropathy IgA 5 2025-10-07
MAGIC AML - Multiarm, Multicenter, RAndomized, Molecularly-GuIded Controlled Trial of Personalized Treatment Strategy - of Acute Myeloid Leu… Recruiting

2023-503394-37-00 Acute Myeloid Leucaemia 5 2024-10-23
Phase 2a non-commercial and non-randomized intervention study evaluating the efficacy of crizotinib in the treatment of children with severe… Recruiting

2024-516607-16-00 Neurofibromatosis type 2 is a genetically determined pr 4 2024-01-17
A Phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaLuate the effIcacy and safety of abeLacimab… Recruiting

2023-503224-66-00 Atrial Fibrillation 5 2023-10-31
Study to evaluate the efficacy of immunosuppression (drugs that suppres natural immunologic response of the human body) in treatment of pati… Recruiting

2024-517484-23-00 Myocarditis, inflammatory cardiomyopathy 6 2022-07-26
ESONIA - The evaluation of efficacy and safety of Nebivolol in the treatment of arterial hypertension in adolescents. Recruiting

2024-518622-32-00 Tensile hypertension (HF) occurs in adolescents with a 5 2022-07-21
A Phase 1 Randomized, Open Label Pharmacokinetic Comparability Study Comparing Pre- and Post-change Teclistamab in Participants with Relapse… Ended

2023-508426-10-00 Relapsed/Refractory Multiple Myeloma 3 2024-06-03
A clinical trial to investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of A… Ended

2023-507052-69-00 Multifocal Motor Neuropathy 4 2023-03-29
Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma Ended

2024-517205-82-00 adrenocortical carcinoma 4 2023-01-20
A double-blind study to evaluate the effectiveness and safety of CAEL-101 in patients with AL amyloidosis Ended

2022-503073-11-00 Stage IIIb cardiac AL amyloidosis 5 2021-02-13
Evaluation of the effect of phenofibrate on the functions of beta cells in children with new diagnosis of type 1 diabetes Ended

2024-517483-34-00 Evaluation of the effect of phenofibrate on the functio 4 2022-09-21
Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Und… Ended

2024-515056-20-00 Acute Coronary Syndrome and Non-valvular Atrial Fibrill 5 2021-07-31
Phase 3 Study of Tamibarotene Plus Azacitidine in Patients Selected for RARA-positive Higher-risk MDS (SELECT-MDS-1) Ended

2023-510361-97-00 Newly Diagnosed RARA-positive Adult Patients with Highe 5